Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Refractory epilepsy: mechanisms and solutions.

Patrick Kwan1, Martin J Brodie

  • 1Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong. patrickkwan@cuhk.edu.hk

Expert Review of Neurotherapeutics
|March 15, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Do the third-generation antiseizure medications provide the "magic bullet" for drug-resistant epilepsy? Focus on cenobamate.

Epilepsia·2025
Same author

Interim analysis of the long-term efficacy and safety of azetukalner in an ongoing open-label extension study following a phase 2b clinical trial (X-TOLE) in adults with focal epilepsy.

Epilepsia open·2025
Same author

The impact of COVID-19 on people with epilepsy: Global results from the coronavirus and epilepsy study.

Epilepsia open·2024
Same author

Editorial: Epidemiology of epilepsy and seizures.

Frontiers in epidemiology·2024
Same author

Work productivity, quality of life, and care needs: An unfolding epilepsy burden revealed in the Australian Epilepsy Project pilot study.

Epilepsia open·2024
Same author

Comparative effectiveness of digital mental healthcare models for adults with epilepsy: A study protocol of a randomized controlled trial.

Epilepsia open·2024

Pharmacoresistance in epilepsy is a significant challenge, as new antiepileptic drugs have not greatly improved outcomes for refractory epilepsy. This review explores current understanding, treatment limits, and novel strategies for intractable epilepsy.

Area of Science:

  • Neurology
  • Pharmacology
  • Epilepsy Research

Background:

  • Pharmacoresistance is a major obstacle in managing epilepsy, significantly impacting patient outcomes.
  • Despite the introduction of numerous antiepileptic drugs since the late 1980s, outcomes for refractory epilepsy have seen limited improvement.
  • Current treatment modalities face limitations in addressing medically intractable epilepsy.

Purpose of the Study:

  • To provide an overview of the current understanding of epilepsy.
  • To discuss the limitations of existing antiepileptic treatments.
  • To review novel strategies being investigated to overcome pharmacoresistance.

Main Methods:

  • Literature review of contemporary epilepsy research.
  • Analysis of biological mechanisms contributing to medical intractability.

Related Experiment Videos

  • Survey of emerging therapeutic strategies for pharmacoresistant epilepsy.

    • Main Results:

    • Epilepsy management is significantly challenged by pharmacoresistance.
    • Existing antiepileptic drugs have not substantially altered the prognosis of refractory epilepsy.
    • Several biological mechanisms underlie the intractability of certain epilepsy cases.

    Conclusions:

    • Understanding the mechanisms of pharmacoresistance is crucial for developing new treatments.
    • Novel therapeutic strategies are under investigation to address the unmet needs in refractory epilepsy.
    • Overcoming pharmacoresistance requires a multi-faceted approach combining biological insights and innovative therapies.